Avaloq Goes Live with First Client in Taiwan
ZURICH, SWITZERLAND, Apr 21, 2022 – (JCN Newswire) – Avaloq, a subsidiary of NEC Corporation,…
Month: April 2022
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Arqit Quantum Inc. (ARQQ, ARQQW) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
PBCO Financial Corporation Reports Q1 2022 Earnings
MEDFORD, Ore.–(BUSINESS WIRE)–PBCO Financial Corporation (OTC PINK: PBCO), the holding company of People’s Bank of…
IBM Stock News: Robbins LLP is Investigating International Business Machines Corporation (IBM)
SAN DIEGO–(BUSINESS WIRE)–$IBM #IBM—The Class: Shareholder rights law firm Robbins LLP is investigating International Business…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
KBRA Assigns Preliminary Ratings to Sunrun Jupiter Issuer 2022-1, LLC
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to three classes of notes issued by Sunrun Jupiter…
Booz Allen Invests in Reveal Technology, Inc.
Strengthens Firm’s Edge Analytics Capabilities, Tactical Decision Making in the Digital Battlespace MCLEAN, Va.–(BUSINESS WIRE)–Booz…
Codiak Presents New Preclinical Data Supporting Development of a Broadly Protective Pan Beta-Coronavirus Vaccine
– Engineered exosome vaccine construct generated durable, comprehensive immunity in vivo – CAMBRIDGE, Mass., April…
Travere Therapeutics Announces Plan for Chief Financial Officer Transition
Laura Clague to step-down as CFO in August 2022 and retire in 2023 Chris Cline,…
Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors for 2022
Company announcement – No. 14 / 2022 Zealand Pharma launches long-term incentive program for Zealand’s Board…
GENFIT Annual Combined General Meeting of May 25, 2022 — Availability of Preparatory Documents
Lille, France; Cambridge, MA; April 20, 2022 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
NGM Bio to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 20, 2022 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (NGM Bio)…
Windtree Therapeutics Announces Late-Breaker Presentation on Phase 2 SEISMiC Study Results of Istaroxime in Early Cardiogenic Shock at the European Society of Cardiology (ESC) Heart Failure Conference
Company to host conference call following the presentation WARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE)…
PacBio to Report First Quarter 2022 Financial Results on May 4, 2022
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that…
Arvig Network Growth Continues With Chicago Expansion
PERHAM, Minn., April 20, 2022 (GLOBE NEWSWIRE) — Arvig has established a network presence within…
iPower Schedules Fiscal Third Quarter 2022 Conference Call for May 16, 2022 at 4:30 p.m. ET
DUARTE, Calif., April 20, 2022 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq:IPW) (“iPower” or the “Company”),…
LBank Exchange Will List Active World Rewards Token (AWRT) on April 22, 2022
Internet City, Dubai–(Newsfile Corp. – April 20, 2022) – LBank Exchange, a global digital asset…
Liberty Oilfield Services Inc. Announces First Quarter 2022 Financial and Operational Results
DENVER–(BUSINESS WIRE)–Liberty Oilfield Services Inc. (NYSE: LBRT; “Liberty” or the “Company”) announced today first quarter…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Netflix, Inc. (NFLX) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 Through 11 years With At Least One F508del Mutation
-Approximately 500 Canadians ages 6-11 are now eligible for TRIKAFTA®– -Vertex has submitted this indication…